Products

What will AGI do for Almitrine mesylate?

This classification denotes a cns stimulant with the molecular formula C26H29F2N7.2CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6RY6V6XM8T, chemically known as 6-4-(bis(4-fluorophenyl)methyl)-1-piperazinyl)-n,n'-di-2-propenyl-1,3,5-triazine-2,4-diamine dimethanesulfonate, but more generally known as almitrine mesylate, which bears US NIH Compound Identifier 6918543. European Medicines Agency schedules almitrine mesylate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05348MIG. Most nations, for tariff purposes, schedule almitrine mesylate under HS 29336980. As of Q4 2014, ALMITRINE MESYLATE remains US FDA's Preferred Term for this commodity. Almitrine mesylate bears US NLM identifiers UMLS ID C0002165 and NCI Concept Code C79962. SMILES: CS(=O)(=O)O.CS(=O)(=O)O.C=CCNC1NC(NC(N1)N2CCN(CC2)C(C3CCC(CC3)F)C4CCC(CC4)F)NCC=C.

How AGI delivers it

Four ways AGI delivers for Almitrine mesylate

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Almitrine mesylate, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Almitrine mesylate, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Almitrine mesylate connects

measured by

  • Active Ingredient Potencymodel
  • Assay Puritymodel
  • Chromatographic Impurity Profilemodel
  • Compound Puritymodel
  • Moisture Contentmodel
  • Salt Stoichiometrymodel